Compare NOG & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NOG | SHC |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 4.4B |
| IPO Year | 2000 | 2020 |
| Metric | NOG | SHC |
|---|---|---|
| Price | $24.41 | $15.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 7 |
| Target Price | ★ $31.14 | $20.33 |
| AVG Volume (30 Days) | 2.4M | ★ 3.6M |
| Earning Date | 04-28-2026 | 05-05-2026 |
| Dividend Yield | ★ 6.44% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.09 |
| Revenue | ★ $2,475,723,000.00 | $1,163,617,000.00 |
| Revenue This Year | $14.07 | $7.51 |
| Revenue Next Year | $4.24 | $6.00 |
| P/E Ratio | ★ N/A | $172.50 |
| Revenue Growth | ★ 11.23 | 5.74 |
| 52 Week Low | $20.18 | $10.80 |
| 52 Week High | $32.62 | $19.85 |
| Indicator | NOG | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.29 | 46.63 |
| Support Level | $23.17 | $15.18 |
| Resistance Level | $25.76 | $16.48 |
| Average True Range (ATR) | 0.80 | 0.46 |
| MACD | -0.19 | -0.06 |
| Stochastic Oscillator | 25.41 | 53.66 |
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.